EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER

Our surveillance was performed for 358 patients with locally advanced and disseminated prostate gland cancer who were treated by analogues of LHRH. Patients in group 1 (n = 222) received treatment with a LHRH analogue, and patients in group 2 (n = 136) received treatment with 75 mg Buserelin-depo 3....

詳細記述

保存先:
書誌詳細
主要な著者: S. V. MISHUGIN, A. A. DROBYAZKO, A. A. MORDOVIN, A. A. GRICKEVICH, I. G. RUSAKOV
フォーマット: Artigo
言語:Russo
出版事項: Remedium Group LLC 2017-06-01
シリーズ:Медицинский совет
主題:
prostate cancer
hormone therapy
agonists of luteinizing hormone releasing hormone
buserelin
prostate-specific antigen
testosterone
オンライン･アクセス:https://www.med-sovet.pro/jour/article/view/1893
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料